(MENAFN- The Conversation) Reader in Gene Delivery and Nanomedicine, Edge Hill University Profile Articles Activity
Dr Aristides Tagalakis is a Reader in Gene Delivery and Nanomedicine at Edge Hill University. The main objective of his research has been the development and implementation of innovative non-viral and nanoparticle technologies in gene therapy for solid tumours, cystic fibrosis, glaucoma, neurological and cardiovascular disorders. These have included a variety of somatic gene transfer approaches towards the efficient, widespread and long-term expression of recombinant genes locally or systemically, silencing of disease-implicated genes, as well as gene repair/editing.
Previously he worked as a Senior Research Fellow at UCL. He holds a PhD from The University of London. He has authored over 80 peer-reviewed publications (original research articles and conference proceedings) in high-impact international journals. He is a member of the 'Nanoagents and Synthetic Formulations Scientific Committee' of the American Society of Gene and Cell Therapy. He is a reviewer of national and international project/programme grants and a regular reviewer of over 50 leading scientific journals. He serves on editorial boards of scientific journals. He is a Fellow of: the Institute of Biomedical Sciences, the Higher Education Academy and the Royal Society of Biology and a Full Member of the Biochemical Society, the Oligonucleotide Therapeutics Society and The British Society for Nanomedicine.
Experience
- 2020–present Reader, Edge Hill University
- 2018–2020 Senior Lecturer, Edge Hill University
- 2011–2017 Senior Research Fellow, UCL
MENAFN12092021000199003603ID1102780334
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.